CAR-T Cell Therapy Market Report

CAR-T Cell Therapy Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Nov 04, 2019
  • PAGES：202
  • REPORT CODE：GMM362542
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide CAR-T Cell Therapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.3% during the forecast period.

    This report presents the market size and development trends by detailing the CAR-T Cell Therapy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the CAR-T Cell Therapy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of CAR-T Cell Therapy industry and will help you to build a panoramic view of the industrial development.

    CAR-T Cell Therapy Market, By Type:

    • CD 19

    • CD 20

    • GD2

    • CD22

    • CD30

    • CD33

    • HER1

    • HER2

    • Meso

    • EGFRvlll

    CAR-T Cell Therapy Market, By Application:

    • Acute Lymphocytic

    • Leukemia

    • Chronic Lymphocytic Leukemia

    • Non Hodgkin Leukemia

    • Multiple Myeloma

    • Pancreatic Cancer

    • Neuroblasta

    • Breast Cancer

    • Acute Myeloid Leukemia

    • Hepatocellular Carcinoma

    • Colorectal Cancer

    Some of the leading players are as follows:

    • Celgene Corporation.

    • Kite Pharma, Inc (Gilead Sciences, Inc)

    • Sorrento Therapeutics Inc.

    • CARsgen Therapeutics, Ltd

    • Kite Pharma, Inc. (Gilead Sciences, Inc.)

    • Aurora Biopharma Inc

    • Mustang Bio, Inc.

    • Novartis International AG.

    • Pfizer, Inc

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 CAR-T Cell Therapy Market: Technology Type Analysis

    • 4.1 CAR-T Cell Therapy Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 CAR-T Cell Therapy Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 CD 19

      • 4.3.2 CD 20

      • 4.3.3 GD2

      • 4.3.4 CD22

      • 4.3.5 CD30

      • 4.3.6 CD33

      • 4.3.7 HER1

      • 4.3.8 HER2

      • 4.3.9 Meso

      • 4.3.10 EGFRvlll

    5 CAR-T Cell Therapy Market: Product Analysis

    • 5.1 CAR-T Cell Therapy Product Market Share Analysis, 2018 & 2026

    • 5.2 CAR-T Cell Therapy Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 CAR-T Cell Therapy Market: Application Analysis

    • 6.1 CAR-T Cell Therapy Application Market Share Analysis, 2018 & 2026

    • 6.2 CAR-T Cell Therapy Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Acute Lymphocytic

      • 6.3.2 Leukemia

      • 6.3.3 Chronic Lymphocytic Leukemia

      • 6.3.4 Non Hodgkin Leukemia

      • 6.3.5 Multiple Myeloma

      • 6.3.6 Pancreatic Cancer

      • 6.3.7 Neuroblasta

      • 6.3.8 Breast Cancer

      • 6.3.9 Acute Myeloid Leukemia

      • 6.3.10 Hepatocellular Carcinoma

      • 6.3.11 Colorectal Cancer

    7 CAR-T Cell Therapy Market: Regional Analysis

    • 7.1 CAR-T Cell Therapy Regional Market Share Analysis, 2018 & 2026

    • 7.2 CAR-T Cell Therapy Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Celgene Corporation.

      • 9.1.1 Celgene Corporation. Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Kite Pharma, Inc (Gilead Sciences, Inc)

      • 9.2.1 Kite Pharma, Inc (Gilead Sciences, Inc) Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Sorrento Therapeutics Inc.

      • 9.3.1 Sorrento Therapeutics Inc. Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 CARsgen Therapeutics, Ltd

      • 9.4.1 CARsgen Therapeutics, Ltd Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Kite Pharma, Inc. (Gilead Sciences, Inc.)

      • 9.5.1 Kite Pharma, Inc. (Gilead Sciences, Inc.) Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Aurora Biopharma Inc

      • 9.6.1 Aurora Biopharma Inc Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Mustang Bio, Inc.

      • 9.7.1 Mustang Bio, Inc. Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Novartis International AG.

      • 9.8.1 Novartis International AG. Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Pfizer, Inc

      • 9.9.1 Pfizer, Inc Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

     

    The List of Tables and Figures (Totals 60 Figures and 159 Tables)

    • Figure CD 19 CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure CD 20 CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure GD2 CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure CD22 CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure CD30 CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure CD33 CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure HER1 CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure HER2 CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure Meso CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure EGFRvlll CAR-T Cell Therapy market, 2015 - 2026 (USD Million)

    • Figure Acute Lymphocytic market, 2015 - 2026 (USD Million)

    • Figure Leukemia market, 2015 - 2026 (USD Million)

    • Figure Chronic Lymphocytic Leukemia market, 2015 - 2026 (USD Million)

    • Figure Non Hodgkin Leukemia market, 2015 - 2026 (USD Million)

    • Figure Multiple Myeloma market, 2015 - 2026 (USD Million)

    • Figure Pancreatic Cancer market, 2015 - 2026 (USD Million)

    • Figure Neuroblasta market, 2015 - 2026 (USD Million)

    • Figure Breast Cancer market, 2015 - 2026 (USD Million)

    • Figure Acute Myeloid Leukemia market, 2015 - 2026 (USD Million)

    • Figure Hepatocellular Carcinoma market, 2015 - 2026 (USD Million)

    • Figure Colorectal Cancer market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America CAR-T Cell Therapy market, by country, 2015 - 2026 (USD Million)

    • Table North America CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table North America CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table North America CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table U.S. CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table U.S. CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Canada CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Canada CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Europe CAR-T Cell Therapy market, by country, 2015 - 2026 (USD Million)

    • Table Europe CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Europe CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Europe CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table U.K. CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table U.K. CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Germany CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Germany CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table France CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table France CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Italy CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Italy CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Spain CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Spain CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific CAR-T Cell Therapy market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table China CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table China CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Japan CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Japan CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table India CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table India CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Latin America CAR-T Cell Therapy market, by country, 2015 - 2026 (USD Million)

    • Table Latin America CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Latin America CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Latin America CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Brazil CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Brazil CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Mexico CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Mexico CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Argentina CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Argentina CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table MEA CAR-T Cell Therapy market, by country, 2015 - 2026 (USD Million)

    • Table MEA CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table MEA CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table MEA CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table South Africa CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table South Africa CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria CAR-T Cell Therapy market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria CAR-T Cell Therapy market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria CAR-T Cell Therapy market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Celgene Corporation. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kite Pharma, Inc (Gilead Sciences, Inc) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sorrento Therapeutics Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CARsgen Therapeutics, Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kite Pharma, Inc. (Gilead Sciences, Inc.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Aurora Biopharma Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mustang Bio, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis International AG. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US